论文部分内容阅读
炎症性肠病(IBD)主要包括溃疡性结肠炎(UC)和克罗恩病(CD),病因至今未明。现认为免疫系统异常是造成IBD炎症和组织损伤的内在因素。本文在总结传统免疫抑制剂的基础上,着重阐述近几年临床或实验应用的新型免疫治疗药物。1传统免疫抑制剂治疗IBD的传统免疫抑制剂包括糖皮质激素
Inflammatory bowel disease (IBD) mainly includes ulcerative colitis (UC) and Crohn’s disease (CD), the etiology has not yet been identified. Now that the immune system abnormalities are caused by IBD inflammation and tissue damage inherent factors. This article summarizes the traditional immunosuppressive agents, based on the last few years of clinical or experimental application of new immunotherapy drugs. Traditional immunosuppressants Traditional immunosuppressive agents for the treatment of IBD include glucocorticoids